HaloperidolThird Party Manufacturing in India

Haloperidol is a first-generation typical antipsychotic of the butyrophenone class. It works primarily by antagonizing dopamine D2 receptors in the mesolimbic and mesocortical pathways of the brain. By blocking these receptors, haloperidol reduces dopaminergic neurotransmission, which is believed to be overactive in the positive symptoms of schizophrenia such as hallucinations and delusions.

Haloperidol exhibits high-affinity dopamine D2 receptor antagonism with slow receptor dissociation kinetics. At higher doses, it also blocks alpha-1 adrenergic receptors and serotonin 5-HT2 receptors, although its affinity for D2 receptors is significantly higher. Unlike atypical antipsychotics, haloperidol has negligible affinity for histamine H1 and muscarinic M1 receptors, which results in a lower incidence of sedation and weight gain but a higher propensity for extrapyramidal side effects. The drug's rapid dissociation from D2 receptors is slower than that of atypical antipsychotics, contributing to its higher rate of movement disorders. It is available in multiple formulations including oral tablets, short-acting intramuscular injections, and long-acting decanoate depot injections for patients requiring sustained antipsychotic coverage.

Therapeutic Uses

Haloperidol is prescribed for the management of a wide range of psychiatric and neurological conditions:

• Schizophrenia: Effective for both acute episodes and maintenance therapy, haloperidol controls positive symptoms such as delusions, hallucinations, and thought disorganization.
• Bipolar Disorder: Used to manage acute manic episodes and agitation.
• Tourette Syndrome: Reduces tics and involuntary motor movements.
• Delirium and Agitation: First-line injectable option for hyperactive delirium and acute agitation in emergency and critical care settings.
• Alcohol Withdrawal: Adjunctive treatment for hallucinations and agitation during alcohol withdrawal.
• Nausea and Vomiting: Used for postoperative and chemotherapy-induced emesis in palliative care.

Why Manufacturers Choose Haloperidol

Haloperidol remains one of the most cost-effective antipsychotics available, priced up to 100-fold lower than newer atypical agents. It is included in the WHO Essential Medicines List and maintains steady demand across psychiatric hospitals, government supply chains, and export markets. Indian manufacturers have well-established capabilities in producing multiple strengths and formulations, including oral tablets, injectables, and depot preparations. The molecule's stable API supply chain, well-characterized impurity profiles, and mature formulation technologies make it an ideal candidate for cost-competitive manufacturing in WHO-GMP certified facilities.

This makes Haloperidol an essential molecule for third party manufacturing in India, with consistent demand from institutional buyers, PCD franchise networks, and export partners across regulated markets.